Full-Time

Clinical Engagement Lead

Beeline Medicines

Beeline Medicines

11-50 employees

Clinical-stage biotech developing precision autoimmune therapies

Compensation Overview

$180k - $235k/yr

+ Bonus + Equity

United States

In Person

Must reside in the United States within the assigned territory; significant travel (50%+) required.

Category
Biology & Biotech (1)
Required Skills
FDA Regulations
Data Analysis
Google Cloud Platform

Get referred to Beeline Medicines

Find people who can refer or advise you

Requirements
  • Bachelor degree in scientific or related discipline required. Advanced degree preferred—MS or MPH in a relevant clinical, biomedical, or pharmaceutical sciences discipline.
  • 8+ years of experience in clinical development, clinical research, clinical operations, or a field-based clinical engagement role within the pharmaceutical or biotech industry.
  • Demonstrated experience managing investigator relationships and supporting clinical trial site activation and enrollment.
  • Experience in immunology, inflammation, or a related therapeutic area strongly preferred.
  • Experience collaborating with CROs, investigative sites, and field medical teams, including MSL partnerships.
  • Strong scientific and clinical knowledge of immunology and inflammation — including disease biology, standard of care, clinical trial design considerations, and the competitive clinical research landscape across relevant immunology and inflammation indications.
  • Expertise in clinical trial site management and investigator engagement — including site feasibility assessment, investigator identification and qualification, site initiation support, and enrollment optimization strategies.
  • Working knowledge of GCP requirements, ICH guidelines, and FDA regulations governing investigator interactions, clinical site oversight, and field-based clinical development activities.
  • Highly self-directed field professional — manages a complex investigator portfolio independently, prioritizes site engagement activities strategically, and operates with minimal supervision across a broad geography.
  • Relationship-driven and trusted clinical trial resource — builds genuine, long-term partnerships with investigators and site staff based on scientific credibility, reliability, and authentic commitment to supporting research excellence.
  • Proactive field intelligence contributor — consistently translates field observations into actionable insights that improve program strategy, site selection, and enrollment performance.
  • Ability to safely and successfully operate a motor vehicle is required. Valid US Driver’s License and a driving record in compliance with company standards.
  • Position may require ability to travel 50%+ as needed of time or more including occasional overnight stay driven by business need.
  • Must be able to work evenings and weekends, as needed, for physician or patient events (both in person and virtual).
  • Depending on geography, must have the ability to manage a multi-state territory with diverse customer base.
Responsibilities
  • Build and manage a portfolio of region/country investigator and clinical site relationships in the I&I therapeutic area — identifying, engaging, and developing long-term partnerships with principal investigators, academic medical centers, community research sites, and subspecialty practices relevant to Beeline's clinical programs.
  • Lead site identification and feasibility activities for clinical trials — conducting operational site assessments, evaluating investigator interest and patient population access, and providing strategic recommendations to Clinical Development and Clinical Operations on site selection and activation.
  • Serve as the primary clinical liaison to regional/country level investigators — facilitating peer-to-peer scientific exchange on Beeline's pipeline, conducting protocol discussions, supporting site initiation and training, and maintaining ongoing engagement with investigators throughout the trial lifecycle.
  • Support clinical trial enrollment and retention at region/country sites — working proactively with investigators and site staff to identify enrollment challenges, implement site-level solutions, and maintain site motivation and engagement across all active Beeline studies.
  • Capture and communicate region/country clinical landscape intelligence — including investigator perspectives, competitive trial activity, site capacity trends, and unmet medical need insights — back to Clinical Development, Medical Affairs, and Commercial teams in a structured, actionable manner.
  • Partner with Medical Affairs MSLs to ensure coordination and alignment of scientific engagement activities at the investigator level — establishing clear boundaries between clinical trial support and medical affairs activities and collaborating to maximize the impact of both.
  • Represent organization clinical and scientific meetings, investigator symposia, disease-area conferences, and site visits — engaging with the clinical research community as a credible, knowledgeable, and trusted organizational representative.
  • Develop and implement site engagement strategies to improve study start-up, enrollment performance, retention, and site satisfaction.
  • Partner closely with investigators, study coordinators, and site staff to support patient identification and recruitment efforts.
  • Provide operational guidance and best practices to sites related to diverse patient enrollment and community engagement.
  • Conduct regular field engagement with investigative sites and community stakeholders to strengthen study execution and recruitment performance.
  • Monitor enrollment trends, site performance metrics, and patient engagement effectiveness using data-driven approaches.
  • Identify enrollment risks proactively and implement mitigation and recovery plans.
  • Perform other duties and responsibilities as assigned.

Beeline Medicines is a clinical-stage biotechnology company focused on precision therapies for autoimmune and inflammatory diseases, formed after in-licensing five programs from Bristol Myers Squibb with a $300 million Series A led by Bain Capital. Its lead programs include afimetoran, an oral lupus therapy that inhibits TLR7 and TLR8, lomedeucitinib, an allosteric TYK2 inhibitor, and two IND-stage biologics targeting IL-18 and IL-10 pathways. The drugs work by modulating specific immune signaling pathways to reduce inflammation, with afimetoran designed to address lupus drivers. The company differentiates itself by using in-licensed assets from a major pharma partner and combining them with an experienced leadership team to push multiple programs toward pivotal trials, starting with Phase 2 for afimetoran targeted for late 2026.

Company Size

11-50

Company Stage

Series A

Total Funding

$426.3M

Headquarters

Stamford, Connecticut

Founded

2025

Get referred to Beeline Medicines

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Afimetoran received FDA Fast Track in May 2025, with Phase 2 readout in H2 2026 enabling pivotal program.
  • BLN-481 and lomedeucitinib trials will start within 12 months, targeting rare autoimmune conditions with new mechanisms.
  • Company secured $426.3M total funding, including $126.3M Series A extension in June 2026, sustaining pipeline advancement.

What critics are saying

  • Afimetoran may fail Phase 2 superiority over GSK TLR inhibitors, causing FDA rejection and Fast Track loss in 6–12 months.
  • Lomedeucitinib could lose psoriasis proof-of-concept due to off-target JAK activity at high doses, halting rare disease development in 9–15 months.
  • BMS may terminate preclinical IL-18/IL-10 biologics license due to missed IND timelines, stripping 40% of pipeline in 12–18 months.

What makes Beeline Medicines unique

  • Beeline in-licensed five autoimmune programs from BMS in July 2025, securing a clinically validated pipeline.
  • CEO Saqib Islam led SpringWorks to a $1B Merck KGaA buyout in 2025, proving commercialization expertise.
  • Afimetoran is equipotent oral TLR7/8 inhibitor, designed for best-in-disease lupus therapy with daily dosing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours

Paid Vacation

Paid Holidays

Health Insurance

Company Equity

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Beeline Medicines
Jun 30th, 2026
Terms of Use - Beeline Medicines

Terms of Use Agreement Effective: April 8, 2026 1. Acceptance of the Terms and Conditions. Beeline Medicines Corporation (herein referred to as “Beeline,” “we,” “us” or “our”) provides and makes available this web site (the “Web Site”). All use of the Web Site is subject to the terms and conditions contained in this Terms of […]